secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001104659-26-015262
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics raises $1M in private placement at $0.60 per share
-------------------------------------------------------------------------------

- Entered Securities Purchase Agreement for $1M total, closings of $500k each on Feb 9, 2026 and ~30 days later.
- Investor receives common stock or pre-funded warrants at $0.60 and common warrants for 120% of shares at $1.00 exercise price.
- First closing occurred on February 9, 2026; second closing subject to conditions.
- Net proceeds for working capital; registration statement to be filed within 45 days.
- Issuance exempt under Section 4(a)(2) and Regulation D; OTCQB ticker BCLI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465926015262/0001104659-26-015262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465926015262/tm266260d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-015262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer